Advertisement
Advertisement
CMMB
Chemomab Therapeutics Ltd. - ADR
1.77
USDSponsored
+0.03
+1.72%
May 08, 15:59 UTC -4
Closed
After-Market
1.77
0.00
0.00%
CMMB Earnings Reports
Positive Surprise Ratio
CMMB beat 4 of 21 last estimates.
19%
Next Report
In 3 Days
Date of Next Report
May 13, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/-$0.15
Implied change from Q4 25 (Revenue/ EPS)
--
/-37.50%
Implied change from Q1 25 (Revenue/ EPS)
--
/-73.21%
Chemomab Therapeutics Ltd. - ADR earnings per share and revenue
On Mar 19, 2026, CMMB reported earnings of -0.24 USD per share (EPS) for Q4 25, beating the estimate of -0.31 USD, resulting in a 24.10% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -8.52% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of -0.15 USD, with revenue projected to reach -- USD, implying an decrease of -37.50% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Werewolf Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.29
Actual
-$0.28
Surprise
+3.68%
argenx SE - ADR
Report Date
May 07, 2026 For Q1 26
Estimate
$5.47
Actual
$5.52
Surprise
+0.86%
Arrowhead Research Corporation
Report Date
May 07, 2026 For Q2 26
Estimate
-$1.16
Actual
-$0.93
Surprise
+20.32%
ImmunityBio, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.09
Surprise
-26.05%
Stoke Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.84
Actual
-$0.79
Surprise
+6.34%
ANI Pharmaceuticals, Inc.
Report Date
May 08, 2026 For Q1 26
Estimate
$1.33
Actual
$2.04
Surprise
+54.04%
Harmony Biosciences Holdings, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.72
Actual
$0.55
Surprise
-24.16%
CytomX Therapeutics, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.10
Surprise
+18.83%
Tectonic Therapeutic, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.20
Actual
-$1.34
Surprise
-11.07%
ALX Oncology Holdings Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.17
Surprise
+24.24%
FAQ
What were Chemomab Therapeutics Ltd. - ADR's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Chemomab Therapeutics Ltd. - ADR reported EPS of -$0.24, beating estimates by 24.1%, and revenue of $0.00, 0% as expectations.
How did the market react to Chemomab Therapeutics Ltd. - ADR's Q4 2025 earnings?
The stock price moved down -8.52%, changed from $1.96 before the earnings release to $1.79 the day after.
When is Chemomab Therapeutics Ltd. - ADR expected to report next?
The next earning report is scheduled for May 13, 2026.
What are the forecasts for Chemomab Therapeutics Ltd. - ADR's next earnings report?
Based on 3
analysts, Chemomab Therapeutics Ltd. - ADR is expected to report EPS of -$0.15 and revenue of -- for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement